|
Dr. Eppstein has over 28 years experience in the pharmaceutical and biotech industries, with the last 18 in entrepreneurial roles. She was founding CEO of Altea Therapeutics, a venture-backed company developing products for pain and diabetes. Previously, she was Vice President of Corporate Development at TheraTech and was involved with the IPO, partnering, achieving profitability and subsequent sale of the company; earlier she was Director of Corporate Development and Head of Biochemistry, Virology and Tumor Biology at Syntex (now Roche). Dr. Eppstein received a B.A., magna cum laude and Phi Beta Kappa from Grinnell College, a Ph.D. with honors in biochemistry from the University of Arkansas, and conducted research in virology and cell biology as an NIH postdoctoral fellow at University of California at Santa Barbara | 